Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Martin Latterich at BioScale; Norman Hardman at Integrated Diagnostics; and More

Premium

BioScale said this week that it has appointed Martin Latterich as chief scientific officer.

Latterich is also chief scientific officer and a board member of the non-profit Nicholas Conor Institute for Pediatric Cancer Research. He has also been a professor at the Proteogenomics Research Institute for Systems Medicine and has held senior management positions at several companies including Diversa and Illumina.


Integrated Diagnostics announced this week that it has named Norman Hardman president of its new InDi Imaging division (see story this issue).

Hardman is currently non-executive director of Chelsea Therapeutics. He was previously the president and CEO of biotech consulting firm Oxalis Partners. Before that he held senior management positions at companies including Amicus Therapeutics, Enzon Pharmaceuticals, Onyx Pharmaceuticals, and GeneMedicine.

InDi also appointed University of California, Los Angeles professor Michael Phelps to the division as an advisor. The inventor of PET imaging technology, Phelps is the chair of the UCLA Department of Molecular and Medical Pharmacology and director of the Crump Institute for Molecular Imaging.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.